Cargando…
Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
For well over 30 years, the botulinum neurotoxin (BoNT) has been used for a large number of indications, some of which however have not been licensed. Admittedly, approval varies in many countries and this permits a large spectrum for evaluation. Thus, BoNT is used for patients with Parkinson’s dise...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910947/ https://www.ncbi.nlm.nih.gov/pubmed/33503872 http://dx.doi.org/10.3390/toxins13020087 |